Literature DB >> 22977593

Serum cytokine profiles in patients with prostate carcinoma.

Eri Tazaki1, Nobuaki Shimizu, Ryota Tanaka, Masakazu Yoshizumi, Hiroshi Kamma, Shigeru Imoto, Tomoyuki Goya, Kunihisa Kozawa, Atsuyoshi Nishina, Hirokazu Kimura.   

Abstract

It has been suggested that various cytokines are associated with the pathophysiology of prostate carcinoma (Pca). We profiled ten cytokines (IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IFN-γ and TNF-α) in the serum levels of 11 patients with organ-confined Pca, 15 with advanced Pca without cachexia, 8 with advanced Pca with cachexia (cachexia group) and 5 healthy males as controls. Cytokines were measured using a highly sensitive fluorescence microsphere system. Compared to the control group, serum levels of all cytokines were significantly higher in the cachexia group, and six cytokines (IL-1β, IL-2, IL-8, IL-12, TNF-α and IFN-γ) were significantly higher in the group with advanced Pca without cachexia. In the group with organ-confined Pca, only IL-1β and IL-12 levels were significantly higher compared to the control group. In the cachexia group, levels of all cytokines apart from TNF-α were significantly higher compared to the group with organ-confined Pca, and levels of four cytokines (IL-2, IL-4, IL-8 and IL-10) were significantly higher compared to the group with advanced Pca without cachexia. These results indicate that i) an aberrance imbalance of cytokine production was associated with the pathophysiology of Pca and cachexia, ii) cytokine profiles in Pca patients were distinct by disease stage, and iii) IL-1β and IL-12 may be applicable as early diagnostic indicators.

Entities:  

Year:  2011        PMID: 22977593      PMCID: PMC3440757          DOI: 10.3892/etm.2011.286

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  28 in total

1.  Interleukin 6 is associated with cachexia in patients with prostate cancer.

Authors:  Kenji Kuroda; Jun Nakashima; Kent Kanao; Eiji Kikuchi; Akira Miyajima; Yutaka Horiguchi; Ken Nakagawa; Mototsugu Oya; Takashi Ohigashi; Masaru Murai
Journal:  Urology       Date:  2007-01       Impact factor: 2.649

2.  Interleukin-6 is an autocrine growth factor in human prostate cancer.

Authors:  D Giri; M Ozen; M Ittmann
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

3.  Interleukin-1 and tumor necrosis factor-alpha inhibit erythropoietin production in vitro.

Authors:  J Fandrey; W E Jelkmann
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

Review 4.  Gene therapy of cancer based on interleukin 12.

Authors:  Bruno Sangro; Ignacio Melero; Cheng Qian; Jesus Prieto
Journal:  Curr Gene Ther       Date:  2005-12       Impact factor: 4.391

5.  Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.

Authors:  K Inoue; J W Slaton; B Y Eve; S J Kim; P Perrotte; M D Balbay; S Yano; M Bar-Eli; R Radinsky; C A Pettaway; C P Dinney
Journal:  Clin Cancer Res       Date:  2000-05       Impact factor: 12.531

6.  Elevation of cytokine levels in cachectic patients with prostate carcinoma.

Authors:  Jesco Pfitzenmaier; Robert Vessella; Celestia S Higano; Jennifer L Noteboom; David Wallace; Eva Corey
Journal:  Cancer       Date:  2003-03-01       Impact factor: 6.860

Review 7.  The cytokine network in asthma and chronic obstructive pulmonary disease.

Authors:  Peter J Barnes
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

8.  Association between tumor necrosis factor in serum and cachexia in patients with prostate cancer.

Authors:  J Nakashima; M Tachibana; M Ueno; A Miyajima; S Baba; M Murai
Journal:  Clin Cancer Res       Date:  1998-07       Impact factor: 12.531

9.  The development of human benign prostatic hyperplasia with age.

Authors:  S J Berry; D S Coffey; P C Walsh; L L Ewing
Journal:  J Urol       Date:  1984-09       Impact factor: 7.450

10.  A novel IL-10 signalling mechanism regulates TIMP-1 expression in human prostate tumour cells.

Authors:  M Wang; Y Hu; M E Stearns
Journal:  Br J Cancer       Date:  2003-05-19       Impact factor: 7.640

View more
  18 in total

1.  MUC1 is upregulated in advanced prostate cancer and is an independent prognostic factor.

Authors:  V Genitsch; I Zlobec; G N Thalmann; A Fleischmann
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-05-10       Impact factor: 5.554

2.  Effect of IL-1β, TNF-α and IGF-1 on trans-endothelial passage of synthetic vectors through an in vitro vascular endothelial barrier of striated muscle.

Authors:  J P Gomez; C Gonçalves; C Pichon; P Midoux
Journal:  Gene Ther       Date:  2017-05-15       Impact factor: 5.250

3.  RELA is sufficient to mediate interleukin-1 repression of androgen receptor expression and activity in an LNCaP disease progression model.

Authors:  Shayna E Thomas-Jardin; Haley Dahl; Mohammed S Kanchwala; Freedom Ha; Joan Jacob; Reshma Soundharrajan; Monica Bautista; Afshan F Nawas; Dexter Robichaux; Ragini Mistry; Vanessa Anunobi; Chao Xing; Nikki A Delk
Journal:  Prostate       Date:  2019-11-15       Impact factor: 4.104

Review 4.  Cancer- and cardiac-induced cachexia: same fate through different inflammatory mediators?

Authors:  Rita Nogueira-Ferreira; Fábio Sousa-Nunes; Adelino Leite-Moreira; Liliana Moreira-Costa; Rui Vitorino; Lúcio Lara Santos; Daniel Moreira-Gonçalves; Rita Ferreira
Journal:  Inflamm Res       Date:  2022-06-09       Impact factor: 6.986

5.  Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia.

Authors:  Melissa J Puppa; Song Gao; Aditi A Narsale; James A Carson
Journal:  FASEB J       Date:  2013-10-21       Impact factor: 5.191

6.  Human tumor infiltrating lymphocytes cooperatively regulate prostate tumor growth in a humanized mouse model.

Authors:  Michael D Roth; Airi Harui
Journal:  J Immunother Cancer       Date:  2015-04-21       Impact factor: 13.751

Review 7.  Serum Cytokinome Profile Evaluation: A Tool to Define New Diagnostic and Prognostic Markers of Cancer Using Multiplexed Bead-Based Immunoassays.

Authors:  Francesca Capone; Eliana Guerriero; Angela Sorice; Giovanni Colonna; Gennaro Ciliberto; Susan Costantini
Journal:  Mediators Inflamm       Date:  2016-12-06       Impact factor: 4.711

8.  Evaluation of inflammatory cytokines and oxidative stress markers in prostate cancer patients undergoing curative radiotherapy.

Authors:  Phebe L Abdel-Messeih; Neveen M Nosseir; Osama H Bakhe
Journal:  Cent Eur J Immunol       Date:  2017-05-08       Impact factor: 2.085

Review 9.  Cancer Cachexia and MicroRNAs.

Authors:  Rodolfo Gonzalez Camargo; Henrique Quintas Teixeira Ribeiro; Murilo Vieira Geraldo; Emídio Matos-Neto; Rodrigo Xavier Neves; Luiz Carlos Carnevali; Felipe Fedrizzi Donatto; Paulo S M Alcântara; José P Ottoch; Marília Seelaender
Journal:  Mediators Inflamm       Date:  2015-10-04       Impact factor: 4.711

Review 10.  Vitamin D and Immune Response: Implications for Prostate Cancer in African Americans.

Authors:  Ken Batai; Adam B Murphy; Larisa Nonn; Rick A Kittles
Journal:  Front Immunol       Date:  2016-02-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.